Analyst Research: Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

108.91USD
30 Jul 2015
Change (% chg)

$-1.39 (-1.26%)
Prev Close
$110.30
Open
$110.44
Day's High
$110.78
Day's Low
$106.09
Volume
330,638
Avg. Vol
608,938
52-wk High
$138.85
52-wk Low
$36.44

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Agios Pharmaceuticals Inc (AGIO-O) 29 Jul 2015 Thomson Reuters Stock Report 11 25.00
ValuEngine Rating and Forecast Report for AGIO 26 Jul 2015 ValuEngine, Inc. 10 25.00
Agios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jul 2015 Reuters Investment Profile 12 20.00
Value Graph: AGIOS PHARMA -- AGIO 23 Jul 2015 Ford Investor Services, Inc. 1 12.00
ValuEngine Industry Report for Medical Products(AGIO) 20 Jul 2015 ValuEngine, Inc. 10 49.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 18 Jul 2015 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 11 Jul 2015 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 4 Jul 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

David Schenkein

57 2013 Chief Executive Officer, Director

J. Duncan Higgons

60 Chief Operating Officer

Glenn Goddard

44 2013 Senior Vice President - Finance

Scott Biller

59 Chief Scientific Officer

Christopher Bowden

54 2014 Chief Medical Officer
Search Stocks